TAIWAN ETF COMPARISON

00898 vs 00919

Cathay Global Genomics Immunology and Medical Revolution ETF compared with CAPITAL TIP CUSTOMIZED TAIWAN SELECT HIGH DIVIDEND EXCHANGE TRADED FUND.

Four ways to read this comparison

Portfolio similarity, historical return, distribution yield and annual fund cost answer different questions.

Portfolio overlap0.00%Low · 0 common securities
Higher 1-year return00919+41.62% vs +46.28%
Higher distribution yield00919— vs 12.44%
Lower annual fee009191.05% vs 0.33%

Price and return trend

Normalized returns make funds with different unit prices comparable. Switch to price mode to view actual TWD prices.

00898-5.67%10.48 TWD・-0.63 TWD
00919-10.31%27.49 TWD・-3.16 TWD

Key metrics

Metric00898
Cathay Global Genomics Immunology and Medical Revolution ETF
00919
CAPITAL TIP CUSTOMIZED TAIWAN SELECT HIGH DIVIDEND EXCHANGE TRADED FUND
Latest closeTWD 10.48TWD 27.49
Assets under managementTWD 1.1BTWD 572.6B
Beneficiaries11,5081,523,591
Trailing 12-month distribution yield—12.44%
Total expense ratio——
Management fee0.85%0.30%
Custody fee0.20%0.04%

Performance and risk

Metric0089800919
1-year return+41.62%+46.28%
3-year return+54.57%+69.19%
5-year return+5.86%—
1-year volatility27.72%20.86%
1-year max drawdown-15.60%-16.75%
1-year Sharpe ratio1.571.4

Returns are price returns. Risk statistics use the available one-year price history and are shown only when sufficient observations exist.

Sector allocation

Weights are based on the latest available disclosed portfolios.

Sector0089800919
Financials
0.00%
54.12%
Computers & Peripherals
0.00%
17.52%
Transportation
0.00%
7.81%
Semiconductors
0.00%
6.11%
Construction
0.00%
2.53%
Other
0.00%
1.80%
Textiles
0.00%
1.59%
Electronics Distribution
0.00%
1.24%
Sports & Leisure
0.00%
1.14%
Other Electronics
0.00%
0.93%
Electronic Components
0.00%
0.81%
Rubber
0.00%
0.61%

Common holdings

0 securities appear in both disclosed portfolios. Data updated Nov 20, 2026.

No data is currently available.

Holdings unique to each ETF

These securities appear in one disclosed portfolio but not the other.

#Security00898 weight
1MRNA · MODERNA INC4.48%
2IOVA · IOVANCE BIOTHERAPEUTICS INC4.30%
31548 · GENSCRIPT BIOTECH CORP4.00%
4TWST · TWIST BIOSCIENCE CORP3.73%
5NTRA · NATERA INC3.70%
6TXG · 10X GENOMICS INC3.50%
7ABBV · AbbVie Inc.3.08%
8LLY · ELI LILLY & CO2.94%
9REGN · REGENERON PHARMACEUTICALS2.85%
10WGS · GENEDX HOLDINGS CORP2.72%
11GH · GUARDANT HEALTH INC2.72%
12GILD · Gilead Sciences Inc2.69%
13BIIB · BIOGEN INC2.56%
14VRTX · VERTEX PHARMACEUTICALS INC2.53%
15PFE · Pfizer Inc2.52%
16GMAB · GENMAB A/S2.47%
17MRK · Merck & Co Inc2.07%
18BLLN · BILLIONTOONE INC.2.07%
19JNJ · Johnson & Johnson2.01%
20QGEN · QIAGEN NV1.99%
216160 · BEIGENE LTD1.97%
22CRSP · CRISPR THERAPEUTICS AG1.94%
23CAI · CARIS LIFE SCIENCES INC1.93%
24ADPT · ADAPTIVE BIOTECHNOLOGIES CORP1.92%
259969 · INNOCARE PHARMA LTD1.87%

Fund profile and disclosure dates

Metric0089800919
IssuerCathay Securities Investment TrustCapital Investment Trust
Tracking index / benchmark——
Listing dateNov 22, 2021Oct 20, 2022
Latest market dateNov 20, 2026Nov 20, 2026
Holdings dateNov 19, 2026Nov 20, 2026
Eligible stock positions4940
Premium / discount+2.34%+0.18%

Switching estimate

Estimate how many units of the other ETF the current market value could purchase.

0089800919
Current market valueTWD 104.8K
Unrealized gain / lossTWD 0
Estimated 00919 units3,812
Estimated annual distribution changeTWD 13K

This estimate excludes brokerage fees, taxes, bid-ask spreads and intraday price movement.

Continue researching this pair

Review each ETF independently or open another published comparison.

Taiwan ETF comparison FAQ

What does portfolio overlap measure?

For each common security, ETF Info takes the smaller of the two portfolio weights and adds those amounts. A higher percentage indicates more similar disclosed stock allocation.

Are historical returns shown with distributions?

Use the label shown for each metric. The long-period return fields are based on the return dataset, while the interactive price chart shows price returns and excludes distributions.

Can the lower-fee or higher-return ETF be considered the winner?

No single metric determines suitability. Fees, risk, liquidity, tracking exposure, distributions and portfolio construction answer different questions.

How to use this comparison

Fees, historical returns and overlap answer different questions. Portfolio overlap shows how similar the latest disclosed holdings are; it does not predict future performance or account for every trading cost, tax or distribution policy.